Drug Profile
L-NDDP
Alternative Names: AR 726; Aroplatin; Liposomal NDDP; NDDP; PlatarLatest Information Update: 11 Oct 2011
Price :
$50
*
At a glance
- Originator Dainippon Sumitomo Pharma; University of Texas M. D. Anderson Cancer Center
- Developer Agenus
- Class Antineoplastics; Platinum complexes
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Discontinued Colorectal cancer; Non-Hodgkin's lymphoma; Solid tumours
Most Recent Events
- 24 Sep 2003 Phase II study data have been added to the adverse events and Cancer therapeutic trials sections ,
- 24 Sep 2003 Antigenics has completed a phase II monotherapy trial in metastatic colorectal cancer patients in the USA
- 18 Jul 2002 Phase-II clinical trials in Colorectal cancer in USA (IV-infusion)